Succinylcholine
From WikiAnesthesia
Revision as of 10:04, 18 February 2021 by Chris Rishel (talk | contribs) (Created page with "{{Infobox drug reference | trade_names =Anectine | drug_class =Depolarizing neuromuscular blocker | drug_class_color =succinylcholine | uses =Paralysis for intubation | co...")
Succinylcholine
| Trade names |
Anectine |
|---|---|
 | |
| Clinical data | |
| Drug class |
Depolarizing neuromuscular blocker |
| Uses |
Paralysis for intubation |
| Contraindications |
History/risk of malignant hyperthermia |
| Routes of administration |
Intravenous, intramuscular |
| Dosage |
0.5-1.5 mg/kg |
| Pharmacodynamics | |
| Mechanism of action |
Depolarizing blockade of neuromuscular junction |
| Adverse effects |
Bradycardia, hyperkalemia, malignant hyperthermia, myalgias |
| Pharmacokinetics | |
| Onset of action |
30-60 seconds (IV) |
| Duration of action |
5-10 minutes (IV) |
| Metabolism |
Plasma cholinesterase |
| Physical and chemical data | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Succinylcholine, also known as suxamethonium, is a short-acting neuromuscular blocker used during intubation.
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Chris Rishel and huckfinne@gmail.com